The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

58 articles for J Cheng


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of N-Substituted (2-Phenylcyclopropyl)methylamines as Functionally Selective Serotonin 2C Receptor Agonists for Potential Use as Antipsychotic Medications.EBI
University of Illinois At Chicago
Further Advances in Optimizing (2-Phenylcyclopropyl)methylamines as Novel Serotonin 2C Agonists: Effects on Hyperlocomotion, Prepulse Inhibition, and Cognition Models.EBI
University of Illinois At Chicago
Optimization of 2-phenylcyclopropylmethylamines as selective serotonin 2C receptor agonists and their evaluation as potential antipsychotic agents.EBI
University of Illinois At Chicago
Design, synthesis and evaluation of novel HDAC inhibitors as potential antitumor agents.EBI
Shanghai Huilun Life Sciences & Technology
Synthesis, biological assay in vitro and molecular docking studies of new imidazopyrazinone derivatives as potential dipeptidyl peptidase IV inhibitors.EBI
East China University of Science and Technology
 
The discovery of CP-96,021 and CP-96,486, balanced, combined, potent and orally active leukotriene D4 (LTD4)/platelet activating factor (PAF) receptor antagonists.EBI
TBA
Synthesis and biological evaluation of multimodal monoaminergic arylpiperazine derivatives with potential antidepressant profile.EBI
University of Chinese Academy of Sciences
Discovery of Novel HDAC3 Inhibitors with PD-L1 Downregulating/Degrading and Antitumor Immune Effects.EBI
Southern Medical University
Synthesis and biological evaluation of 4-imidazolidinone-containing compounds as potent inhibitors of the MDM2/p53 interaction.EBI
Nanjing University of Chinese Medicine
Transformation of a Dopamine DEBI
Shanghaitech University
Design and Synthesis of Triazole-Containing HDAC Inhibitors That Induce Antitumor Effects and Immune Response.EBI
Xuzhou Medical University
Discovery of JN122, a Spiroindoline-Containing Molecule that Inhibits MDM2/p53 Protein-Protein Interaction and Exerts Robust In Vivo Antitumor Efficacy.EBI
Shanghai Institute of Materia Medica
A chemical perspective on the modulation of TEAD transcriptional activities: Recent progress, challenges, and opportunities.EBI
Shanghai Institute of Materia Medica
Optical-Controlled Kinetic Switch: Fine-Tuning of the Residence Time of an Antagonist Binding to the Vasopressin VEBI
Xuzhou Medical University
2-Phenylcyclopropylmethylamine (PCPMA) as a privileged scaffold for central nervous system drug design.EBI
Shanghaitech University
Discovery of Highly Potent Nicotinamide Phosphoribosyltransferase Degraders for Efficient Treatment of Ovarian Cancer.EBI
Second Military Medical University
Optimization of P2YEBI
East China Normal University
Discovery of a Potent FLT3 Inhibitor (LT-850-166) with the Capacity of Overcoming a Variety of FLT3 Mutations.EBI
China Pharmaceutical University
Ispinesib as an Effective Warhead for the Design of Autophagosome-Tethering Chimeras: Discovery of Potent Degraders of Nicotinamide Phosphoribosyltransferase (NAMPT).EBI
Second Military Medical University
Dual-acting antitumor agents targeting the AEBI
Shanghaitech University
Long Residence Time at the Vasopressin VEBI
Xuzhou Medical University
Making Protein Degradation Visible: Discovery of Theranostic PROTACs for Detecting and Degrading NAMPT.EBI
Second Military Medical University (Navy Medical University)
FLT3 Inhibitors in Acute Myeloid Leukemia: Challenges and Recent Developments in Overcoming Resistance.EBI
China Pharmaceutical University
Isothiazolopyridones: synthesis, structure, and biological activity of a new class of antibacterial agents.EBI
Achillion Pharmaceuticals
Isothiazoloquinolones containing functionalized aromatic hydrocarbons at the 7-position: synthesis and in vitro activity of a series of potent antibacterial agents with diminished cytotoxicity in human cells.EBI
Achillion Pharmaceuticals
Biological evaluation of isothiazoloquinolones containing aromatic heterocycles at the 7-position: In vitro activity of a series of potent antibacterial agents that are effective against methicillin-resistant Staphylococcus aureus.EBI
Achillion Pharmaceuticals
Identification and structural analysis of a selective tropomyosin receptor kinase C (TRKC) inhibitor.EBI
China Pharmaceutical University
Carbon-silicon switch led to the discovery of novel synthetic cannabinoids with therapeutic effects in a mouse model of multiple sclerosis.EBI
Shanghaitech University
Identification and In Silico Binding Study of a Highly Potent DENV NS2B-NS3 Covalent Inhibitor.EBI
Shenyang Pharmaceutical University
Hydrophobic Tagging-Induced Degradation of PDEδ in Colon Cancer Cells.EBI
Second Military Medical University
Structure-Based Design of Dual-Acting Compounds Targeting Adenosine AEBI
Shanghaitech University
2-Phenylcyclopropylmethylamine Derivatives as Dopamine DEBI
Shanghaitech University
Structure-Activity Relationship Studies of Coumarin-like Diacid Derivatives as Human G Protein-Coupled Receptor-35 (hGPR35) Agonists and a Consequent New Design Principle.EBI
Chinese Academy of Sciences
Design and Discovery of Functionally Selective Serotonin 2C (5-HTEBI
University of Illinois At Chicago
Discovery of Novel PDEδ Degraders for the Treatment of KRAS Mutant Colorectal Cancer.EBI
Second Military Medical University
Antimycobacterial Rufomycin Analogues from EBI
University of Illinois At Chicago
Development of selective mono or dual PROTAC degrader probe of CDK isoforms.EBI
Sichuan University and Collaborative Innovation Center of Biotherapy
Design and Synthesis of Bitopic 2-Phenylcyclopropylmethylamine (PCPMA) Derivatives as Selective Dopamine D3 Receptor Ligands.EBI
Shanghaitech University
Structure-activity relationships for a class of inhibitors of purine nucleoside phosphorylase.EBI
University of Michigan
Scaffold Hopping of Natural Product Evodiamine: Discovery of a Novel Antitumor Scaffold with Excellent Potency against Colon Cancer.EBI
Second Military Medical University
Biased Ligands of G Protein-Coupled Receptors (GPCRs): Structure-Functional Selectivity Relationships (SFSRs) and Therapeutic Potential.EBI
Shanghaitech University
Design of fluorinated cyclopropane derivatives of 2-phenylcyclopropylmethylamine leading to identification of a selective serotonin 2C (5-HTEBI
University of Illinois At Chicago
Design, synthesis, antitumor activities and biological studies of novel diaryl substituted fused heterocycles as dual ligands targeting tubulin and katanin.EBI
Fudan University
Discovery of 4,6-EBI
Hubei University of Technology
Discovery of Novel Aryl Carboxamide Derivatives as Hypoxia-Inducible Factor 1α Signaling Inhibitors with Potent Activities of Anticancer Metastasis.EBI
Anhui Medical University
Homology modeling and atomic level binding study of GABA(A) receptor with novel enaminone amides.EBI
Wuhan Institute of Technology
Dual targeting of DNA gyrase and topoisomerase IV: target interactions of heteroaryl isothiazolones in Staphylococcus aureus.EBI
Achillion Pharmaceuticals
Isothiazoloquinolones with enhanced antistaphylococcal activities against multidrug-resistant strains: effects of structural modifications at the 6-, 7-, and 8-positions.EBI
Achillion Pharmaceuticals
Synthesis and biological evaluation at nicotinic acetylcholine receptors of N-arylalkyl- and N-aryl-7-azabicyclo[2.2.1]heptanes.EBI
University of New Orleans
b-Annulated 1,4-dihydropyridines as Notch inhibitors.EBI
Human Biomolecular Research Institute
Discovery of novel Syk/PDGFR-α/c-Kit inhibitors as multi-targeting drugs to treat rheumatoid arthritis.EBI
East China University of Science & Technology
Novel tertiary sulfonamides as potent anti-cancer agents.EBI
Human Biomolecular Research Institute
Therapeutically active compounds and their methods of useBDB
Servier Pharmaceuticals
TRIAZOLO WRN INHIBITORSBDB
Nimbus Wadjet
PHOSPHONATES AS INHIBITORS OF ENPP1 AND CDNPBDB
Stingray Therapeutics
3-HYDROXY-5-(ISOXAZOL-5-YL) PYRIDINE FORMYLGLYCINE COMPOUNDS, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USEBDB
China Pharmaceutical University
HETEROAROMATIC COMPOUNDSBDB
Astrazeneca
Tertiary amines for use in the treatment of cardiac disordersBDB
Universitetet I Oslo